Investors.coherus.com

  1. Home
  2. Investors.coherus.com

Coherus Announces U.S. FDA Approval of YUSIMRY™ …

WEBYUSIMRY is indicated for plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, Crohn’s disease, and …

Actived: 4 days ago

URL: https://investors.coherus.com/news-releases/news-release-details/coherus-announces-us-fda-approval-yusimrytm-adalimumab-aqvh

Coherus BioSciences, Inc. Coherus Announces Positive Results of

WEB- UDENYCA ® On-Body Injector (OBI) Achieved Both Pharmacokinetic and Pharmacodynamic Bioequivalence in Randomized Clinical Trial- Coherus plans to seek …

Category:  Health Go Health

FDA Approves Coherus’ CIMERLI™ (ranibizumab-eqrn) as the

WEB- CIMERLI™ is Coherus’ third FDA-approved product and the first of four new product launches planned by the end of 2023 - - First CIMERLI™ product sales …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Management to …

WEBREDWOOD CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” Nasdaq: CHRS), today announced that senior management will present at …

Category:  Health Go Health

Coherus BioSciences, Inc. Press Releases

WEBCoherus BioSciences Announces New Employment Inducement Grants. Feb 23, 2024. 1. 2. ›. ». Press releases for Coherus BioSciences, Inc., a commercial-stage …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences to Present at the …

WEBREDWOOD CITY, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Management to …

WEBREDWOOD CITY, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced that senior management will be presenting at the …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Appoints Rosh …

WEB- Dr. Dias is a biotech and pharma industry executive with more than 20 years of global experience launching oncology products - REDWOOD CITY, Calif., …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus and Junshi Biosciences …

WEB– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to chemotherapy alone in high and low PD-L1 …

Category:  Health Go Health

Coherus BioSciences, Inc. UBS Global Healthcare Conference

WEBUBS Global Healthcare Conference. May 23, 2023 1:1s for conference attendees only. Follow Us

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Appoints Health …

WEBJim Healy, Director since 2014, steps down from the Coherus board. REDWOOD CITY, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Management to …

WEBREDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Reports Third …

WEBNon-GAAP net loss for the third quarter of 2021 was $26.6 million, or $ (0.34) per share on a diluted basis, compared to non-GAAP net income of $39.7 million, …

Category:  Health Go Health

Coherus BioSciences, Inc. 42nd Annual J.P. Morgan Healthcare …

WEBSupporting Materials. Coherus JP Morgan Presentation – January 2024. Events for Coherus BioSciences, Inc., a commercial-stage biopharmacetucial company …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Appoints Dr.

WEB– Recognized biopharma commercialization and market access leader to support Coherus’ strategic vision and multiple product launches – REDWOOD CITY, Calif., July 20, 2023 …

Category:  Health Go Health

Coherus and Junshi Biosciences Announce FDA Acceptance of BLA …

WEBFDA has granted the toripalimab BLA Priority Review with a target action date of April 2022; REDWOOD CITY, Calif. and SHANGHAI, China, Nov. 01, 2021 (GLOBE …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus Announces U.S. Launch of …

WEB–Innovative design enables five-minute pegfilgrastim-cbqv delivery time – – Unique, automatic, retractable needle mechanism engineered to maximize safety and …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus to Acquire Surface Oncology

WEBTransaction Details. Under the terms of the agreement, Coherus will issue shares of its common stock at a price of $5.2831 per share to acquire all outstanding …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus Launches YUSIMRY™, a

WEB–$995 per carton (two 40 mg/0.8 mL autoinjectors) represents a discount of more than 85% compared to Humira® – – YUSIMRY™ meets high unmet need by …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Ehealth in medical practice

 › Health insurance benefits news

 › Cranberry good for health

 › Cdc healthy people guidelines

 › Jbs western mental health clinic

 › Healthy bowels look like

 › Be healthy cafe okc

 › Indiana health care lawsuit

 › Healthy relationships fact sheet

 › Barwon health covid research

Recently Searched

 › Panama city beach health department

 › Illovo life health care accounting

 › Healthcare 21 moneyrea phone number

 › Health index by country

 › Dr. kamath wellstar health system center for spine 4586

 › Help with mental health uk

 › Law governing health studios

 › Health indicators in medical records

 › Main line health help desk

 › Healthcare 21 blarney business park